Central Drugs Standard Control Organisation

Bharat Biotech’s Covaxin Highly Immunogenic in Children Aged 2-18

Bharat Biotech said that the neutralizing antibodies in children were on an average 1.7 times higher than in adults and that data from over 50 million doses administered to children in India revealed that side effects were minimal.